Pharmacologic Treatment of Opioid Addiction During Pregnancy
详细信息 查看全文
- 作者：Lori Keough Lori_Keough@uml.eduAuthor Vitae ; Heidi Collins FantasiaAuthor Vitae
- 关键词：buprenorphine ; medication-assisted treatment ; methadone ; opioid ; pregnancy
- 刊名：Nursing for Women's Health
- 出版年：2017
- 出版时间：February-March 2017
- 年：2017
- 卷：21
- 期：1
- 页码：34-44
- 全文大小：3576 K
- 卷排序：21
文摘
Opioid addiction during pregnancy presents a treatment challenge to clinicians and women alike. Untreated addiction can lead to poor maternal and fetal health outcomes. Medication-assisted treatment is the standard of care, and methadone is the current drug of choice for treatment. Emerging evidence also supports the use of buprenorphine during pregnancy. Both methadone and buprenorphine have risks and benefits that should be explored before initiating treatment. Clinicians who work in obstetrics and in addiction treatment can collaborate and coordinate treatment to ensure optimal maternal and fetal outcomes. Women undergoing treatment will require frequent monitoring, particularly in the third trimester. Neonates born to women receiving treatment may have withdrawal symptoms and require additional treatment.